drug development & manufacturing accelerator

Executive Summary

Quotient Sciences is a UK-based Contract Research, Development, and Manufacturing Organization (CRDMO) that differentiates itself through a fully integrated service model spanning formulation development, real-time GMP manufacturing, and clinical testing. This unique approach enables biotech and pharmaceutical clients to accelerate drug programs from pre-clinical stages through to commercial supply, significantly reducing both time and cost. Founded in 1994 and headquartered in Nottingham, the company has built a strong reputation for speed and efficiency, serving a broad range of clients with complex development needs. By offering a single point of accountability and eliminating traditional handoffs between separate CROs and CMOs, Quotient Sciences provides a compelling value proposition in an increasingly competitive outsourcing landscape. The company's sustained operation over three decades and its focus on integrated services position it well for continued growth as the industry demands faster, more cost-effective drug development pathways.

Upcoming Catalysts (preview)

• Q3 2026Launch of new integrated drug development platform60% success
• Q4 2026Strategic partnership with large pharma for accelerated program50% success
• Q2 2026Expansion of manufacturing facility to increase capacity70% success